EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY-NC 4.0

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

Anna Langenbruch, Nicole Mohr, Valerie Andrees, Ihno Kessens, Adam Reich, Magdalena Czarnecka-Operacz, Luis Puig, Esteban Dauden, Lars Iversen, Matthias Augustin

Acta Dermato-Venereologica · 2023

DOI: 10.2340/actadv.v103.6532 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Anna Langenbruch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Germany. a.langenbruch@u…. Hauptthemen laut MEDLINE: Quality of Life, Psoriasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the PsoBarrier EU study is to compare the quality and processes of psoriasis care in four European countries with different healthcare systems, based on validated quality indicators. This cross-sectional survey was conducted in dermatology centres in Denmark, Germany, Poland and Spain on 1,304 patients, using standardized patient and physician questionnaires. Measured by quality of psoriasis care indicators, patients in Poland had the most critical outcomes, such as the highest disease severity (Psoriasis Area and Severity Index; PASI) and lowest health-related quality of life (Dermatology Life Quality Index; DLQI). This indicates differences in psoriasis care, with Polish participants experiencing more severe psoriasis and its consequences. Differences in the healthcare systems, which create barriers to accessing treatments, could explain variations in quality of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifePsoriasisHumansCross-Sectional StudiesEuropePoland

Autor:innen und Institutionen

  • Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Germany. a.langenbruch@uke.de.
  • Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Germany.
  • Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszów, Poland.
  • Department of Dermatology, Medical University of Poznan, Poland.
  • Department of Dermatology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Department of Dermatology, Hospital Universitario de la Princesa, Madrid, Spain.

Zitieren

APA

Langenbruch, A., Mohr, N., Andrees, V., Kessens, I., Reich, A., Czarnecka-Operacz, M., Puig, L., Dauden, E., Iversen, L., & Augustin, M. (2023). PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.6532

Vancouver

Langenbruch A, Mohr N, Andrees V, Kessens I, Reich A, Czarnecka-Operacz M, et al. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.6532

BibTeX
@article{Langenbruch2023,
  author = {Langenbruch, Anna and Mohr, Nicole and Andrees, Valerie and Kessens, Ihno and Reich, Adam and Czarnecka-Operacz, Magdalena and Puig, Luis and Dauden, Esteban and Iversen, Lars and Augustin, Matthias},
  title = {PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries},
  journal = {Acta Dermato-Venereologica},
  year = {2023},
  doi = {10.2340/actadv.v103.6532}
}
Kostenlos starten →